• No results found

18 results with keyword: 'high diffusion weighted imaging progressive multifocal leukoencephalopathy patients'

High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients

However the rim on b3000 diffusion-weighted imaging (DWI) contains a higher proportion of low ADC values (arrows), suggesting that the more stringent delineation of the lesion rim

Protected

N/A

7
0
0
2021
High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients

However the rim on b3000 diffusion-weighted imaging (DWI) contains a higher proportion of low ADC values ( arrows ), suggesting that the more stringent delineation of the lesion rim

Protected

N/A

7
0
0
2021
Natalizumab-Related Progressive Multifocal Leukoencephalopathy-Immune Reconstitution Inflammatory Syndrome: a Case Report Highlighting Clinical and MRI Features

Keywords: magnetic resonance imaging, natalizumab, multiple sclerosis, progressive multifocal leukoencephalopathy, immune reconstitution inflammatory

Protected

N/A

5
0
0
2020
Progressive multifocal leukoencephalopathy

JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Hall CD, Dafni U, Simpson D,

Protected

N/A

18
0
0
2021
Alberta Health. AADL Approved Product List - Orthotic Benefits. Pricing effective April 1, 2015

For generic custom made stabilizing knee brace for failed total knee replacements, neurological deficits (defined by prescription), quadriceps weakness, knee extension greater than

Protected

N/A

27
0
0
2021
AMA Aboriginal and Torres Strait Islander Health Audit Report 2012: Progress to Date and Challenges that Remain

Mainstream primary care services, such as private general practices and community health clinics, also have a strong potential to improve the quality of the primary care they

Protected

N/A

24
0
0
2021
SUBSTITUTION I.. f(ax + b)

● When looking at the THEORY, STANDARD INTEGRALS, AN- SWERS or TIPS pages, use the Back button (at the bottom of the page) to return to the exercises.. ● Use the

Protected

N/A

21
0
0
2021
EMA and Progressive Multifocal Leukoencephalopathy.

• Limited data regarding the risk of drug-induced PML beyond 3 years of MAbs treatment;. • The long-term impact of IRIS therapies is

Protected

N/A

24
0
0
2021
Use of Diffusion Weighted Imaging to Evaluate the Initial Response of Progressive Multifocal Leukoencephalopathy to Highly Active Antiretroviral Therapy: Early Experience

ADC/DWI characteristics of PML lesions differ in patients with rapid and slow clinical progression following the initia- tion of HAART therapy, and these findings may aid in

Protected

N/A

5
0
0
2020
Progressive multifocal leukoencephalopathy after fingolimod treatment

We describe the characteristics of the 15 patients with fi ngolimod-associated progressive multifocal leukoencephalopathy (PML) identi fi ed from the Novartis data safety base and

Protected

N/A

9
0
0
2020
Genotyping of JC Virus in Clinical Samples in North Eastern Iran

JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased

Protected

N/A

7
0
0
2020
Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy

: Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy.

Protected

N/A

7
0
0
2020
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients

MRI showed an enlargement of the frontal lesion whose posterior border had diffusion restriction on DWI; contrast enhancement appeared at T1-weighted (T1w)

Protected

N/A

30
0
0
2021
Natalizumab therapy, 2013

Natalizumab- associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis patients: survival and functio- nal outcome when asymptomatic at diagnosis. In AAN

Protected

N/A

9
0
0
2021
JC Virus Quasispecies Analysis Reveals a Complex Viral Population Underlying Progressive Multifocal Leukoencephalopathy and Supports Viral Dissemination via the Hematogenous Route

By applying 454 sequencing on NCCR DNA amplified from body fluid samples (urine, plasma, and cerebrospinal fluid [CSF]) from 19 progressive multifocal leukoencephalopathy

Protected

N/A

8
0
0
2019
Progressive Multifocal Leukoencephalopathy: Current Insights

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.

Protected

N/A

13
0
0
2020
High angular resolution diffusion imaging with stimulated echoes: Compensation and correction in experiment design and analysis

Abbreviations used: DTI, diffusion tensor imaging; DWI, diffusion-weighted imaging; DWS, diffusion-weighted spectroscopy; FA, fractional anisotropy; HARDI, high angular

Protected

N/A

8
0
0
2021
Whole-body diffusion-weighted imaging in
chronic recurrent multifocal osteomyelitis in
children: Whole-body diffusion-weighted imaging inchronic recurrent multifocal osteomyelitis inchildren

Table 2. MR images of 12-year old girl with known CRMO. a) STIR-weighted images show diaphyseal edematous bone marrow involvement, periostal reaction of the left humerus b) axial

Protected

N/A

12
0
0
2021

Upload more documents and download any material studies right away!